Forte Biosciences, Inc. (Nasdaq: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced the pricing of a public offering of 5,709,936 ...
The AARP report found that most of those surveyed (59 percent) are significantly worried about these crimes, and becoming a ...
Better Home & Finance Holding Company (Nasdaq: BETR) (“Better,” the “Company,” “we” or “our”), a leading AI-powered homeownership company, today announced the pricing of an underwritten public ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果